A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical trial NCT05314010 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05314010
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2025-02-21
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.